FAKTOR-OPTIONSSCHEIN - HALEON Share Price

Certificat

DE000MD7LDG3

Real-time Bid/Ask 14:04:30 05/06/2024 BST
8.95 EUR / 8.99 EUR +0.79% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month+3.97%
1 month-6.81%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/06/24 8.82 -0.90%
04/06/24 8.9 +3.25%
03/06/24 8.62 +0.70%
31/05/24 8.56 -0.81%
30/05/24 8.63 +4.10%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 12:03 pm

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MD7LDG
ISINDE000MD7LDG3
Date issued 30/08/2022
Strike 258.2 p
Maturity Unlimited
Parity 0.09 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.55
Lowest since issue 5.91
Spread 0.04
Spread %0.45%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.227 GBP
Average target price
3.62 GBP
Spread / Average Target
+12.18%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW